Regulation of mesangial cell function by vasodilatory signaling molecules

Cardiovascular Research

Volumn 51, Issue 3, 2001, Pages 463-469

  Buschhausen, Lutz ^a   Seibold, Stefan ^a   Gross, Oliver ^a   Matthaeus, Tilman ^a   Weber, Manfred ^a   Schulze Lohoff, Eckhard ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenosine; Natriuretic peptide; Nitric oxide; Prostaglandine

Indexed keywords

ADENOSINE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN E2; VASOCONSTRICTOR AGENT;

ARTERIOLE; BLOOD PRESSURE; CELL FUNCTION; CELL PROLIFERATION; DIABETIC NEPHROPATHY; DISEASE COURSE; EXTRACELLULAR MATRIX; GLOMERULOPATHY; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ADENOSINE; ATRIAL NATRIURETIC FACTOR; GLOMERULAR MESANGIUM; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; NITRIC OXIDE; SIGNAL TRANSDUCTION; VASODILATION;

EID: 0035882440     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00340-6     Document Type: Review

References (82)

1. Pathophysiology of progressive nephropathies
2. Roles of mesangium in glomerular function
3. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix
4. Glomerular cells in vitro versus the glomerulus in vivo
5. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)
6. The endocrine heart and natriuretic peptides: Histochemistry, cell biology, and functional aspects of the renal urodilatin system
7. Molecular biology of the natriuretic peptides and their receptors
8. Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli
9. Characterization of natriuretic peptide receptors in cultured cells
10. Physiological role of silent receptors of atrial natriuretic factor
11. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor
12. Effects of severe hemorrhage on plasma ANP and glomerular ANP receptors
13. 2+ mobilization and contraction in glomerular mesangial cells
14. Mechanism of atrial natriuretic factor-induced inhibition of rat mesangial cell mitogenesis
15. Diadenosine polyphosphates and atrial natriuretic peptide are antiproliferative in rat mesangial cells
16. Stimulation of cyclic GMP synthesis in human cultured glomerular cells by atrial natriuretic peptide
17. Atrial natriuretic peptide induces the expression of MKP-1, a mitogen -activated protein kinase phosphatase, in glomerular mesangial cells
18. Atrial natriuretic peptide inhibits endothelin-1-induced activation of JNK in glomerular mesangial cells
19. Atrial natriuretic peptide inhibits endothelin-1-induced activation of mitogen-activated protein kinase in cultured rat mesangial cells
20. Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin
21. Biological receptors mediate anti-proliferative action of atrial natriuretic peptide in cultured mesangial cells
22. Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: Role of cGMP-dependent protein kinase
23. Atrial natriuretic peptide inhibits angiotensin II-induced contraction of isolated glomeruli and cultured glomerular mesangial cells of rats: the role of calcium
24. Effects of cardiac natriuretic peptides on oxidized low-density lipoprotein- and lysophosphatidylcholine-induced human mesangial cell migration
25. Atrial natriuretic peptide stimulates the expression of transforming growth factor-beta in cultured murine mesangial cells: Relationship to suppression of proliferation
26. 2+ induced by atrial natriuretic hormone, S-nitroso-N-acetylpenicillamine and 8-bromo cyclic GMP in cultured rat mesangial cells
27. Effect of atrial natriuretic factor on cytosolic free calcium in rat glomerular mesangial cells
28. A mechanism by which atrial natriuretic factor mediates its glomerular actions
29. Natriuretic peptides increase a K+ conductance in rat mesangial cells
30. Mechanism of activation by cGMP-dependent protein kinase of large Ca(2+)-activated K+ channels in mesangial cells
31. Role of large Ca(2+)-activated K+ channels in regulation of mesangial contraction by nitroprusside and ANP
32. Natriuretic peptides and diadenosine polyphosphates modulate pH regulation of rat mesangial cells
33. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo
34. Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation
35. Glomerular actions of nitric oxide
36. Biochemistry and molecular biology of nitric oxide synthases
37. Nitric oxide and tubuloglomerular feedback
38. The nitric oxide pathway in glomerulonephritis
39. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis
40. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis
41. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis
42. Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators
43. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells
44. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells
45. Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II
46. Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components
47. The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells
48. Nitric oxide stimulates the stress-activated protein kinase p38 in rat renal mesangial cells
49. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1 beta and cAMP in rat mesangial cells
50. Transforming growth factor-beta 2 inhibits interleukin 1 beta-induced expression of inducible nitric oxide synthase in rat renal mesangial cells
51. AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells
52. Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells
53. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells
54. Effects of endogenously produced arachidonic acid metabolites on rat mesangial cell proliferation
55. Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells
56. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions
57. Cytokine stimulation of prostaglandin production inhibits the proliferation of serum-stimulated mesangial cells
58. Prostaglandin E2 and atriopeptin III oppose the contractile effect of angiotensin II in rat kidney mesangial cell cultures
59. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells
60. The effect of prostaglandin E2 on mRNA expression and secretion of collagens I, III, and IV and fibronectin in cultured rat mesangial cells
61. Effects of prostaglandin E2 on mesangial cell migration
62. Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells
63. Localization of the prostacyclin receptor in human kidney
64. Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat
65. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology
66. Adenosine and tubuloglomerular feedback
67. Adenosine receptor subtypes: Characterization and therapeutic regulation
68. Adenosine receptor subtypes
69. Adenosine formed by 5-nucleotidase mediates tubuloglomerular feedback
70. 2+ in cultured rat mesangial cells
71. Adenosine induces mesangial cell contraction by an A1-type receptor
72. Adenosine activates mesangial cell proliferation
73. Dysregulation of extracellular adenosine levels by vascular smooth muscle cells from spontaneously hypertensive rats
74. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats
75. Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors
76. Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist
77. Natriuretic effect of adenosine A1-receptor blockade in rats
78. Attenuation of anti-Thy 1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents
79. Vasopeptidase inhibitors: An emerging class of cardiovascular drugs
80. Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure
81. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomized trial
82. Vasopeptidase inhibition